Predicting treatable traits for long-acting bronchodilators in patients with stable COPD

PURPOSE: There is currently no measure to predict a treatability of long-acting β-2 agonist (LABA) or long-acting muscarinic antagonist (LAMA) in patients with chronic obstructive pulmonary disease (COPD). We aimed to build prediction models for the treatment response to these bronchodilators, in or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jieun, Kim, Ki Tae, Lee, Ji-Hyun, Kim, Eun Kyung, Kim, Tae-Hyung, Yoo, Kwang Ha, Lee, Jae Seung, Kim, Woo Jin, Kim, Ju Han, Oh, Yeon-Mok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732547/
https://www.ncbi.nlm.nih.gov/pubmed/29263660
http://dx.doi.org/10.2147/COPD.S151909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732547/
https://www.ncbi.nlm.nih.gov/pubmed/29263660
http://dx.doi.org/10.2147/COPD.S151909

Ejemplares similares